Hikma: FDA approves GLP-1 generic
On Dec. 23, the FDA approved Hikma Pharmaceuticals' liraglutide injection, a generic version of Novo Nordisk's Victoza.
Read full article »
Hikma is an England-based multinational pharmaceutical company that develops, manufactures and markets generic and specialty medicines for the healthcare sector.
Read more